Document is current
Any future updates will be listed below
-
Authors
Rolando, Maurizio
del Castillo, José Manuel Benitez
Cebollero, Maria Antonia
Messmer, Elisabeth M. https://orcid.org/0000-0003-1299-3882
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 23 June 2025
Revised: 16 October 2025
Accepted: 26 November 2025
First Online: 20 December 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Sterling Institutional Review Board (Atlanta, GA, USA) and the Alpha Institutional Review Board (San Clemente, CA, USA), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: M. Rolando has no conflict of interest. J. M. Benitez del Castillo has collaborations with Sun Pharma, Bausch + Lomb, Théa, Santen, Alcon, Viatris, Nordic Pharma. M. A. Cebollero is staff of Sun Pharma International B.V. E. M. Messmer is consultant and/or speaker for the following companies: Alcon/Novartis, Bausch & Lomb, Bayer, Novaliq, Santen GmbH, Sifi, Théa Pharma GmbH, TRB-Chemedica AG, Visufarma; Bausch & Lomb, Bayer, Fidia, GlaxoSmithKline; Alfa Intes, Daiichi-Sankyo, DMG, Kala, Nordic, Sanofi, Shire, Sun Pharma, Tarsus, Viatris.
: Informed consent was obtained from all individual participants included in the studies.
